Submitted by Anonymous (not verified) on 18 March 2026 - 15:53
Human medicines European public assessment report (EPAR): Deltyba, delamanid, Date of authorisation: 27/04/2014, Date of refusal: 25/07/2013, Revision: 28, Status: Authorised
Source:
